Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercebiotech.com

FierceBiotech

Get the latest updates from FierceBiotech directly as they happen.

Follow now 326 followers

Latest posts

Last updated about 2 hours ago

Charles River to close cell therapy CDMO site, lay off 20 staffers

about 2 hours ago

Charles River Laboratories is continuing its run of layoffs by announcing the...

FDA signals tailored approach to ‘carefully shepherd’ CAR-T therapy for autoimmune diseases

about 3 hours ago

As the first CAR-T treatment for an autoimmune disease draws ever closer...

Pfizer CEO says pipeline pruning is mostly finished after 6 more early-stage culls, $4.4B in impairment charges

about 3 hours ago

Pfizer has pumped the brakes on six early-stage assets, including three being...

Fledgling biotech Exxel plans $13M IPO to succeed where other FAAH inhibitors have failed

about 3 hours ago

Exxel Pharma is eyeing a listing on the NYSE American to fund...

Pfizer's $10B monthly GLP-1 bet generates competitive weight loss in phase 2b

about 6 hours ago

Patients in a phase 2b trial kept losing weight after switching to...

Quest launches residual disease blood test for multiple myeloma

about 8 hours ago

Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple...

NMD flunks rare disease trial, but flexes secondary data to accelerate program

about 10 hours ago

A phase 2a trial of NMD Pharma’s rare disease prospect ignaseclant has...

Novo’s CagriSema tops semaglutide in ph. 3 diabetes study

about 24 hours ago

Novo Nordisk’s GLP-1/amylin combo has topped blockbuster semaglutide in a phase 3...

GSK plans to lay off up to 350 R&D workers across US, UK

1 day ago

GSK is trimming its R&D team, a move that is expected to...

Thermo Fisher trims Massachusetts headcount with Franklin site closure

1 day ago

Thermo Fisher is continuing its recent layoff spree with a fresh round...

GSK gives back rights to Wave's genetic disease RNA editor

1 day ago

Wave Life Sciences has the fate of its lead RNA editing candidate...

Daiichi stops internal development of next-wave ADC as key Datroway readout delayed again

1 day ago

Daiichi Sankyo’s development of ADCs continues to hit turbulence. The company has...